alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
REPORT OF INDEPENDENT
AUDITORS


The Board of Directors
Nuveen Exchange-Traded Funds

In planning and performing our audit of the financial statements
of each of the Nuveen Exchange-Traded Funds listed in Exhibit
A attached hereto (the "Funds") for the year ended May 31,
2000, we considered its internal control, including control
activities for safeguarding securities, to determine our auditing
procedures for the purpose of expressing our opinion on the
financial statements and to comply with the requirements of Form N-SAR,
and not to provide assurance on internal control.


The management of the Funds is responsible for establishing
 and maintaining internal control.  In fulfilling this
responsibility, estimates and judgments by management are
required to assess the expected benefits and related costs of
internal control. Generally, internal controls that are relevant to
an audit pertain to the entity's objective of preparing financial
statements for external purposes that are fairly presented in
conformity with generally accepted accounting principles.
Those internal controls include the safeguarding of assets
against unauthorized acquisition, use, or disposition.


Because of inherent limitations in any internal control,
misstatements due to errors or fraud may occur and not be
detected.  Also, projections of any evaluation of internal control
to future periods are subject to the risk that internal control may
become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.


Our consideration of internal control would not necessarily
disclose all matters in internal control that might be material
weaknesses under standards established by the American
Institute of Certified Public Accountants. A material weakness is
a condition in which the design or operation of one or more of
the specific internal control components does not reduce to a
relatively low level the risk that errors or fraud in amounts that
would be material in relation to the financial statements being
audited may occur and not be detected within a timely period by
employees in the normal course of performing their assigned
functions.  However, we noted no matters involving internal
control, including control activities for safeguarding securities,
and its operation that we consider to be material weaknesses as
defined above as of May 31, 2000.


This report is intended solely for the information and use of the
Board of Directors and management of the Nuveen Exchange-
Traded Funds and the Securities and Exchange Commission and
is not intended to be and should not be used by anyone other
than these specified parties.


ERNST & YOUNG LLP

/s/- ERNST & YOUNG LLP


Chicago, Illinois
July 21, 2000

Exhibit A


Funds with May Fiscal Year End

Nuveen Select Maturities Municipal Fund
Nuveen Georgia Premium Income Municipal Fund
Nuveen Maryland Premium Income Municipal Fund
Nuveen North Carolina Premium Income Municipal Fund
Nuveen Virginia Premium Income Municipal Fund
Nuveen Connecticut Premium Income Municipal Fund
Nuveen Missouri Premium Income Municipal Fund
Nuveen Massachusetts Premium Income Municipal Fund
```

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                            AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

       In connection with the Quarterly Report of Rampart Studios , Inc.
(the "Company") on Form 10-Q for three month period ended June 30, 2010 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, G.J. de Klerk, certify pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the
best of my knowledge and belief:

       1.  The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

       2.  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: April 19, 2013

                                         By:  /s/ G.J. de Klerk
                                              -------------------------------
                                              G.J. de Klerk
                                              Chief Executive Officer and
                                              Chief Financial Officer
                                              (Principal Executive Officer)
                                              (Principal Financial Officer)
```
# Official Journal L 226/2016

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 226 |
| | |
| English edition | Legislation | Volume 5919 August 2016 |

ISSN 1977-0677

Official Journal

of the European Union

L 226

English edition

Legislation

Volume 5919 August 2016

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Commission Implementing Regulation (EU) 2016/1377 of 4 August 2016 laying down common requirements for service providers and the oversight in air traffic management/air navigation services and other air traffic management network functions, repealing Regulation (EC) No 482/2008, Implementing Regulations (EU) No 1034/2011 and (EU) No 1035/2011 and amending Regulation (EU) No 677/2011 (
  1
  ) | 1 |

Contents

II   Non-legislative acts

page

REGULATIONS

*

Commission Implementing Regulation (EU) 2016/1377 of 4 August 2016 laying down common requirements for service providers and the oversight in air traffic management/air navigation services and other air traffic management network functions, repealing Regulation (EC) No 482/2008, Implementing Regulations (EU) No 1034/2011 and (EU) No 1035/2011 and amending Regulation (EU) No 677/2011 (
  1
  )

1

1

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
Exhibit
99.4








CERTIFICATE
PURSUANT TO


18 U.S.C.
SECTION 1350


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002








In
connection with the Quarterly Report (the “Report”) on the Form 10-Q of Brand
Neue Corp. (the “Company”) for the three months ended June 30, 2009, as filed
with the Securities and Exchange Commission on the date hereof, I, Ashmi Deo,
Chief Accounting Officer, Chief Financial Officer and Director, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and
belief:





1. The
Quarterly Report fully complies with the requirements of Section 13 (a) or 15
(d) of the Securities and Exchange Act of 1934, as amended; and





2. The
information contained in this Quarterly Report fairly presents, in all material
respects, the financial condition and results of operation of the
Company.








Date: 
August 17, 2009





ASHMI
DEO       .


Ashmi
Deo


Chief
Accounting Officer


Chief
Financial Officer and Director








-1-
<PAGE>


                                                                  Exhibit 21.1.1

LIST OF SUBSIDIARIES


WHOLLY-OWNED

927563 Ontario Inc.
927564 Ontario Inc.
Med-Emerg Inc.
Med Plus Health Centres Ltd.
JC Medical Management Inc.
Med-Emerg Urgent Care Centres Inc.
Med-Emerg Family Health Centres Inc.
Med-Emerg Britannia Urgent Care Inc.
Med-Emerg Elmvale Clinic Inc.

75%-OWNED

Doctors on Call Ltd.

51%-OWNED

York Lanes Health Centre Inc.
Caremedics (Elmvale) Inc.

45%-OWNED

Medical Urgent Care Inc.
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 1432 Introduced in Senate (IS)]

106th CONGRESS
  1st Session
                                S. 1432

     To suspend temporarily the duty on dark couverture chocolate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 26, 1999

Mr. Lautenberg introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
     To suspend temporarily the duty on dark couverture chocolate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DARK COUVERTURE CHOCOLATE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

      

``    9902.18.06    Dark couverture   Free              No Change         No Change         On or before 12/
                     chocolate                                                               31/2002          ''
                     (provided for                                                                             .
                     in subheading
                     1806.20.50)....

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to articles entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
**Exhibit
      31.1**





**Rule
      13a-14(a) / 15d-14(a) Certification of Chief Executive
      Officer**





I,
      Dr.
      Ramesh Zacharias, certify that:





1.
      I have
      reviewed this report on Form 10-K of Med-Emerg International Inc.;





2.
      Based
      on my knowledge, this report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statements made,
      in
      light of the circumstances under which such statements were made, not misleading
      with respect to the period covered by this report;





3.
      Based
      on my knowledge, the consolidated financial statements, and other financial
      information included in this report, fairly present in all material respects
      the
      financial condition, results of operations and cash flows of the registrant
      as
      of, and for, the periods presented in this report;





4.
      The
      registrant's other certifying officer and I are responsible for establishing
      and
      maintaining disclosure controls and procedures (as defined in Exchange Act
      Rules 13a-14 and 15d-14) for the registrant and we have:





a)
      designed
      such disclosure controls and procedures to ensure that material information
      relating to the registrant, including its consolidated subsidiaries, is made
      known to us by others within those entities, particularly during the period
      in
      which this report is being prepared;





b)
      evaluated
      the effectiveness of the registrant's disclosure controls and procedures and
      presented in this report our conclusions about the effectiveness of the
      disclosure controls and procedures, as of the end of the period covered by
      this
      report based on such evaluation; and





c)
      disclosed
      in this report any change in the registrant’s internal control over financial
      reporting that occurred during the registrant’s fiscal year that has materially
      affected, or is reasonably likely to materially affect, the registrant’s
      internal control over financial reporting.





5.
      The
      registrant's other certifying officer and I have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the
      registrant's auditors and the audit committee of the registrant's board of
      directors (or persons performing the equivalent functions):





a)
      all
      significant deficiencies and material weaknesses in the design or operation
      of
      internal control over financial reporting which are reasonably likely to
      adversely affect the registrant’s ability to record, process, summarize and
      report financial information; and





b)
      any fraud,
      whether or not material, that involves management or other employees who have
      a
      significant role in the registrant's internal control over financial
      reporting.








Date: 
      March 31, 2006




/s/Dr.
                Ramesh ZachariasDr.
                Ramesh ZachariasChief
                Executive Officer
Bars cool slowly as they are “walked”

the 77 ft across 420-ft-long cooling
bed.
AMENDMENT NO. 1 TO LICENSE AGREEMENT


 


This Amendment No. 1 to the License Agreement
(“Amendment”), having an effective , date of April 7, 2014 (“Amendment Effective Date”), is made and entered
by and between Ohio State Innovation Foundation, located at 1524 North High Street, Columbus, Ohio 43201 (“OSIF”) and
Microlin Bio, Inc., a New York based corporation located at 302A West 12th, New York, NY 10014 (“Licensee”).


 


BACKGROUND


 


OSIF and Licensee entered into a Patent
& Technology License Agreement dated September 6, 2013 (“License Agreement”) with respect to OSIF # A2014-0294;
and


 


OSIF and Licensee would like to amend and
modify the License Agreement as identified below and such amendment shall be incorporated as part of the License Agreement.


 


The parties agree as follows:


 


		1.	Definitions. All capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to
such terms in the License Agreement.



 


		2.	In Section 1, Patent Rights/Technology Rights shall be amended to include the information below:
	 	 	 



	
        App. No./

        Date of

        Filing

        [Tech ID#]
	 	Title	 	Inventor(s)	 	
        Jointly Owned?

        (Y/N; if Y, with

        whom?)
	 	Prosecution Counsel
	
        61/975,366

        April 4, 2014

        [2014-218]
	 	Lipid Nanoparticle Compositions and Methods of Making and Methods of Using the Same	 	R. Lee	 	x No	 	MacMillan, Sobanski, and Todd LLC


 


 


		3.	In Section 3.1(a), “Patent expenses due upon Effective Date” shall be amended to include the information below:
	 	 	 



	
        Patent expenses 

        due upon

        Effective Date
	 	Amount	 	
        based on invoices received 

        as of:

	Tech ID#2014-218	 	Current Estimate: $8,500 – invoice for 4/04/14 filing not yet received 	 	Reimbursement of past patent cost and future patent cost due upon Licensee receipt of invoice from OSIF


 




    	 1 of 3



    	 



    

 


		4.	Counterparts. This Amendment may be executed in any number of counterparts, each of which shall be deemed to be an original
and all of which together shall constitute an agreement, notwithstanding that all parties are not signatories to the same counterpart.



 


		5.	Continued Force and Effect. Except as provided in this Amendment, all terms, conditions, and provisions of the License
Agreement shall remain and continue in full force and effect as provided therein.



 


IN WITNESS WHEREOF, the parties hereto have
entered into this Amendment effective as of the Amendment Effective Date.


 


[AUTHORIZED SIGNATURES APPEAR ON THE FOLLOWING
PAGE]


 




    	 2 of 3



    	 



    

 


	OHIO STATE INNOVATION FOUNDATION	 	MICROLIN BIO, INC.
	 	 	 	 	 
	By:	/s/ Timothy R. Wright	 	By:	/s/ Joseph Hernandez
	 	 	 	 	 
	Name:	Timothy R. Wright	 	Name:	Joseph Hernandez
	 	 	 	 	 
	Title:	President	 	Title:	CEO & President
	 	 	 	 	 
	Date:	4-8-14	 	Date:	4-10-14


 




    	3 of 3
##### 



Exhibit 32.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 10-K for the year ended December 31, 2004, (the
Report) of The Hillman Companies, Inc. (the Registrant), as filed with the Securities and
Exchange Commission on the date hereof; I, Max W. Hillman, the Chief Executive Officer of the
Registrant, certify, to the best of my knowledge, that: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and (2) The information contained in the Report fairly presents, in all material respects, the
financial conditions and results of operations of the Registrant. _/s/ Max W. Hillman ___Name: Max W. HillmanDate: March 25, 2005
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

**1003 CAF 14-01301**  PRESENT: SCUDDER, P.J., SMITH, LINDLEY, VALENTINO, AND WHALEN, JJ.

IN THE MATTER OF JOHN A. SABATINO, PETITIONER-APPELLANT,
V ORDER
CHRISTINE M. AUSMAN, RESPONDENT-RESPONDENT, AND KAYLA FARMER, RESPONDENT.

JEREMY D. ALEXANDER, UTICA, FOR PETITIONER-APPELLANT.
MARIAN J. CERIO, CANASTOTA, FOR RESPONDENT-RESPONDENT.
PAUL A. NORTON, ATTORNEY FOR THE CHILD, CLINTON.

Appeal from an order of the Family Court, Oneida County (Joan E. Shkane, J.), entered June 10, 2014 in a proceeding pursuant to Family Court Act article 6. The order dismissed the petition. Now, upon reading and filing the stipulation of discontinuance signed by appellant on June 2, 2015, by the attorneys for the parties on June 2 and 16, 2015, and by the Attorney for the Child on June 9, 2015, It is hereby ORDERED that said appeal is unanimously dismissed without costs upon stipulation.

Entered: October 2, 2015 Frances E. Cafarell Clerk of the Court
[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

 FOR THE ELEVENTH CIRCUIT

 ________________________

 No. 11-15679 

Non-Argument Calendar

 ________________________

 D.C. Docket No. 0:05-cr-60098-WPD-1

UNITED STATES OF AMERICA, 

Plaintiff-Appellee,

 versus

WILLIAM MOYO, 

Defendant-Appellant.

________________________

 Appeal from the United States District Court

 for the Southern District of Florida

 ________________________

(July 13, 2012)

Before MARCUS, PRYOR and BLACK, Circuit Judges.

PER CURIAM:

William Moyo appeals the denial of his motion to reduce his sentence. 18

Case: 11-15679 Date Filed: 07/13/2012 Page: 1 of 3 
U.S.C. § 3582(c)(2). We affirm.

In September 2009, Moyo pleaded guilty to distributing and possessing with

intent to distribute five or more grams of crack cocaine. 21 U.S.C. § 841(a). 

Because Moyo was responsible 49.5 grams of crack cocaine and was a career

offender, his presentence investigation report provided an offense level of 34,

United States Sentencing Guidelines Manual § 4B1.1(b) (Nov. 2008), and then

reduced that level by three points for Moyo’s acceptance of responsibility, id.

§ 3E1.1. With a criminal history category of VI, the report provided an advisory

guideline range between 188 and 235 months of imprisonment. 

At Moyo’s sentencing hearing, the parties agreed that Moyo should be

sentenced as if his offense involved powder cocaine, which would lower Moyo’s

total offense level to 29 and subject him to a guideline range between 151 and 188

months of imprisonment. The district court accepted the recommendation to apply

the lower offense level and sentenced Moyo to 151 months of imprisonment.

On November 8, 2011, Moyo moved to reduce his sentence. 18 U.S.C. §

3582(c)(2). Moyo argued that he was entitled to a two-level reduction of his

offense level under unspecified “amendments” to the Fair Sentencing Act of 2010

that altered the offense levels in Section 2D1.1 applicable to crack cocaine

offenses. Moyo argued that he had not received the full benefit intended by the

2

Case: 11-15679 Date Filed: 07/13/2012 Page: 2 of 3 
Act and that the Act “should . . . apply to career offenders that are charged with

cocaine an[d]/or crack offenses.”

The district court denied Moyo’s motion to reduce. The district court ruled

that “USSG § 1B1.1 only allows a reduction for Amendment 750 where the

original sentence was derived from USSG § 2D1.1 and not the career offender

provision, USSG § 4B1.1.”

Moyo argues, for the first time on appeal, that he was entitled to a reduction

of sentence under Amendment 706, but that provision, which became effective in

November 2007, was not a “subsequent” amendment under section 3582(c)(2). 

The district court did not err.

The denial of Moyo’s motion to reduce is AFFIRMED.

3

Case: 11-15679 Date Filed: 07/13/2012 Page: 3 of 3
```

[Federal Register Volume 73, Number 127 (Tuesday, July 1, 2008)]
[Notices]
[Page 37515]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-1401]

-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

Sunshine Federal Register Notice

Agency Holding the Meetings: Nuclear Regulatory Commission.

Date: Weeks of June 30, July 7, 14, 21, 28, August 4, 2008.

Place: Commissioners' Conference Room, 11555 Rockville Pike, Rockville, 
Maryland.

Status: Public and Closed.

Week of June 30, 2008

Tuesday, July 1, 2008

    9 a.m. Hearing: Diablo Canyon, 10 CFR part 2, subpart K Proceeding, 
Oral Arguments (Public Meeting), (Contact: John Cordes, 301 415-1600).

    This meeting will be Webcast live at the Web address--http://www.nrc.gov.

Week of July 7, 2008--Tentative

    There are no meetings scheduled for the week of July 7, 2008.

Week of July 14, 2008--Tentative

Thursday, July 17, 2008

    1 p.m. Briefing on Fire Protection Issues (Public Meeting), 
(Contact: Alex Klein, 301 415-2822).
    This meeting will be Webcast live at the Web address--http://www.nrc.gov.

Week of July 21, 2008--Tentative

Wednesday, July 23, 2008

    1:30 p.m. Discussion of Security Issues (Closed--Ex. 1 & 3).

Thursday, July 24, 2008

    1:30 p.m. Discussion of Security Issues (Closed--Ex. 1 & 3).

Week of July 28, 2008--Tentative

    There are no meetings scheduled for the week of July 28, 2008.

Week of August 4, 2008--Tentative

    There are no meetings scheduled for the week of August 4, 2008.
* * * * *
    * The schedule for Commission meetings is subject to change on 
short notice. To verify the status of meetings, call (recording)--(301) 
415-1292. Contact person for more information: Michelle Schroll, (301) 
415-1662.
* * * * *
    The NRC Commission Meeting Schedule can be found on the Internet 
at: http://www.nrc.gov/about-nrc/policy-making/schedule.html.
* * * * *
    The NRC provides reasonable accommodation to individuals with 
disabilities where appropriate. If you need a reasonable accommodation 
to participate in these public meetings, or need this meeting notice or 
the transcript or other information from the public meetings in another 
format (e.g., braille, large print), please notify the NRC's Disability 
Program Coordinator, Rohn Brown, at 301-492-2279, TDD: 301-415-2100, or 
by e-mail at [email protected]. Determinations on requests for reasonable 
accommodation will be made on a case-by-case basis.
* * * * *
    This notice is distributed by mail to several hundred subscribers; 
if you no longer wish to receive it, or would like to be added to the 
distribution, please contact the Office of the Secretary, Washington, 
DC 20555 (301-415-1969). In addition, distribution of this meeting 
notice over the Internet system is available. If you are interested in 
receiving this Commission meeting schedule electronically, please send 
an electronic message to [email protected].

    Dated: June 26, 2008.
R. Michelle Schroll,
Office of the Secretary.
[FR Doc. 08-1401 Filed 6-27-08; 10:20am]
BILLING CODE 7590-01-P
```